Xigduo XR(dapagliflozin / metformin HCl)

Type 2 diabetes — combination oral therapy. BOXED WARNING: lactic acidosis risk.

1 DTP program

From $181.59/mo

1 platform

FDA-Approved Indications

Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

via AZ Patient Direct · AstraZeneca

$181.59/mo

$181.59 (home delivery only). Eligible patients: as little as $0. HSA/FSA eligible. BOXED WARNING: lactic acidosis.

Eligibility

Valid Rx required. US patients only. Home delivery only. BOXED WARNING for lactic acidosis — prescriber context required.

Government eligibility determined during enrollment. Verify with manufacturer.

Last verified: Mar 2026

Not sure which Xigduo XR program fits your situation?